West Oak Capital’s Organon & Co OGN Stock Holding History

West Oak Capital’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-22	Closed	-$400	–	312
2024 Q3	$400	Hold	22	–	–	﹤0.01%	295
2024 Q2	$455	Sell	22 -50	-69%	-$994	﹤0.01%	310
2024 Q1	$1K	Hold	72	–	–	﹤0.01%	289
2023 Q4	$1K	Hold	72	–	–	﹤0.01%	293
2023 Q3	$1K	Hold	72	–	–	﹤0.01%	291
2023 Q2	$1.5K	Sell	72 -30	-29%	-$652	﹤0.01%	290
2023 Q1	$2.4K	Hold	102	–	–	﹤0.01%	290
2022 Q4	$3K	Hold	102	–	–	﹤0.01%	254
2022 Q3	$2K	Hold	102	–	–	﹤0.01%	303
2022 Q2	$3K	Hold	102	–	–	﹤0.01%	293
2022 Q1	$4K	Sell	102 -37	-27%	-$1.26K	﹤0.01%	303
2021 Q4	$4K	Sell	139 -2,096	-94%	-$68.3K	﹤0.01%	314
2021 Q3	$73K	Sell	2,235 -195	-8%	-$6.24K	0.03%	173
2021 Q2	$74K	Buy	+2,430	New	+$80K	0.03%	169

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

West Oak Capital's OGN Position: Q4 2024 in Review

West Oak Capital sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 22 shares — an estimated $400 sold.

West Oak Capital first reported a position in OGN in Q2 2021 and held it in 14 quarters. The position peaked at $74K in Q2 2021. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

West Oak Capital reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
West Oak Capital sold 22 Organon & Co shares in Q4 2024, an estimated $400.
West Oak Capital first reported a position in Organon & Co in Q2 2021 and held it in 14 quarters.
West Oak Capital's Organon & Co position peaked at $74K in Q2 2021.
740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on West Oak Capital's 13F filing for Q4 2024, filed 10 Jan 2025.